GSE127197
Attenuation of progesterone driven mammary stem cells population by telapristone acetate
ovariectomized mice treated with E2+Progesterone, E2+Progesterone+TPA,  E2+Progesterone+RU486 and sham for 14 days, followed by isolation of luminal mature, luminal progenitor and mammary stem cells through FACS and RNASeq performed for each cell lineage population. TPA and RU486 treated mice show significant decline in mammary stem cell pool pulation comapared to EP treated mice Overall design: RNA-seq of luminal mature, luminal progenitor and mammary stem cells from ovariectomized mice treated with  E2+Progesterone, E2+Progesterone+TPA,  E2+Progesterone+RU486 or sham for 14 days. contributor: Artificial Intelligene (AI, www.artificialintelligene.com)